Corvus Pharmaceuticals (NASDAQ:CRVS) lost ~34% in the premarket on Wednesday after the company announced early results from a ...

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

Corvus Robotics' autonomous drones are revolutionizing warehouse inventory management with precision and efficiency.

The Bill & Melinda Gates Foundation will invest up to $50 million in Tessera’s in vivo sickle cell therapy. Elsewhere, Cara ...

Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in AD showed mixed results. See why I ...

I Saw U: Wearing a Green Jacket at Trader Joe’s, Exchanging Art at Corvus, and Catching a Flight from Denver You were the ...

During the randomized, double-blind, placebo-controlled trial, 12 patients received soquelitinib oral twice per day and 4 patients received placebo for 28 days and were followed up for 30 days. The ...

Mizuho views the selloff yesterday in shares of Corvus Pharmaceuticals (CRVS) following the Phase 1 data for soquelitinib in atopic dermatitis ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients ...

Nukkleus Inc. NUKK gained 55.1% to $18.42 in pre-market trading. Nukkleus shares jumped 755% on Tuesday after the company ...

U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Tuesday. Heico reported ...

Corvus Robotics, a provider of autonomous inventory management systems, today announced that it has recruited Rob Stevens, ...